Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks at one-month high on Vodafone capital return

Fri, 21st Feb 2014 11:45

- Vodafone and RBS provide a lift- Vodafone capital return lifts sentiment- IHG, Glencore Xstrata hit by downgrades- FTSE 100 at highest level in monthtechMARK 2,884.38 +0.29%FTSE 100 6,827.26 +0.21%FTSE 250 16,401.56 +0.20%UK stocks rose to levels not seen in a month on Friday as a windfall for investors at Vodafone and rumoured restructuring plans at RBS gave sentiment a lift.Markets were particularly buoyant this morning as investors speculated about which stocks could benefit from Vodafone shareholders redistributing their cash following the group's $130bn deal to sell its 45% stake in Verizon Wireless.According to analysts at Bank of America Merrill Lynch, the deal, which completes today, will be the largest capital return in corporate history and will have a drastic impact on UK trading volumes over the next few weeks.The FTSE 100 had pared gains by midday but was still trading 0.2% higher at 6,827; it has not closed above this level since January 21st. "London's main index holds above the 6,800 level for now, putting it in a position to challenge the January high of 6,867; providing the positive mood is sustained into the final week of February," said Chris Beauchamp, Market Analyst at IG. He said that the current rally "may have a little further to run".Investors largely shrugged off data this morning showing a worse-than-expected 1.5% fall in UK retail sales volumes in January. Vodafone, RBS and Glaxo provide a liftTelecoms titan Vodafone was making decent gains this morning with shareholders today set to receive a windfall from the company's sale of its holding in its US joint venture with Verizon.RBS was higher amid reports that the bank will announce plans to slash as many as 30,000 jobs, reducing its staff count to the lowest levels in more than 10 years. The speculation comes ahead of the group's 2013 results due out next week, alongside which it is expected to unveil a massive restructuring programme of its divisions.Pharmaceuticals giant GlaxoSmithKline edged higher after European regulators recommended marketing authorisation for umeclidinium, its once-daily treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.Millennium & Copthorne, the hotel firm, jumped after reporting record revenues and profits for 2013 as fourth-quarter results were boosted by the one-off sale of the bulk of the Glyndebourne development in Singapore.Sector peer InterContinental Hotels Group, however, was trading in the red after Credit Suisse lowered its recommendation from 'neutral' to 'underperform', pointing out that the shares are trading within just 4% of their all-time high at a price-to-earnings ratio of 23.Glencore Xstrata was also lower after JPMorgan Cazenove downgraded its rating on the stock from 'overweight' to 'neutral', saying that its peers have overtaken it in terms of capital returns potential.BAE Systems, which disappointed the market with its 2014 guidance yesterday, bounced slightly this morning after Societe Generale raised the stock from 'hold' to 'buy'.FTSE 100 - RisersRoyal Bank of Scotland Group (RBS) 364.10p +2.36%BAE Systems (BA.) 409.00p +2.15%ARM Holdings (ARM) 965.00p +1.90%Vodafone Group (VOD) 233.65p +1.76%Persimmon (PSN) 1,460.00p +1.60%Weir Group (WEIR) 2,355.00p +1.16%Travis Perkins (TPK) 1,984.00p +0.92%Randgold Resources Ltd. (RRS) 4,825.00p +0.81%Severn Trent (SVT) 1,812.00p +0.78%Wolseley (WOS) 3,342.00p +0.75%FTSE 100 - FallersInterContinental Hotels Group (IHG) 1,922.00p -2.68%IMI (IMI) 1,530.00p -2.24%Smiths Group (SMIN) 1,361.00p -2.09%Bunzl (BNZL) 1,469.00p -1.34%easyJet (EZJ) 1,727.00p -1.20%Prudential (PRU) 1,340.00p -1.11%International Consolidated Airlines Group SA (CDI) (IAG) 445.70p -1.07%Meggitt (MGGT) 509.00p -1.07%Glencore Xstrata (GLEN) 336.90p -1.04%ITV (ITV) 205.70p -1.01%FTSE 250 - RisersIP Group (IPO) 231.00p +7.89%Millennium & Copthorne Hotels (MLC) 598.50p +4.72%Essentra (ESNT) 882.00p +4.38%Centamin (DI) (CEY) 52.35p +3.77%Imagination Technologies Group (IMG) 187.90p +2.96%Ocado Group (OCDO) 598.00p +2.48%Big Yellow Group (BYG) 562.00p +2.46%RPC Group (RPC) 630.00p +2.36%Hunting (HTG) 838.00p +2.20%Polymetal International (POLY) 655.00p +2.18%FTSE 250 - FallersVesuvius (VSVS) 458.20p -2.86%Domino's Pizza Group (DOM) 535.00p -2.37%Evraz (EVR) 81.80p -1.56%Rank Group (RNK) 145.00p -1.56%3i Group (III) 400.50p -1.50%PZ Cussons (PZC) 358.80p -1.46%Hellermanntyton Group (HTY) 305.30p -1.45%Synthomer (SYNT) 270.20p -1.39%Cranswick (CWK) 1,288.00p -1.38%Bank of Georgia Holdings (BGEO) 2,375.00p -1.29%BC
More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.